Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FANCM inhibitors(FA complementation group M inhibitors), RMI1 inhibitors(RecQ mediated genome instability 1 inhibitors), RMI2 inhibitors(RecQ mediated genome instability 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC27H28N4O3 |
InChIKeyROTCTSYSZSYNHB-UHFFFAOYSA-N |
CAS Registry622795-76-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bloom Syndrome | Discovery | AU | 09 Aug 2023 | |
Fanconi Anemia | Discovery | AU | 09 Aug 2023 |